RecruitingNCT05412849

Radiation Field, Dose and Fractionation Related to Mandibular Complications

Is the Radiation Field, Dose and Fractionation Crucial for the Development of Mandibular Complications When Treating Malignancies in the Oropharyngeal Region?


Sponsor

Lund University Hospital

Enrollment

120 participants

Start Date

Jan 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Radiotherapy is inhibiting the healing capacity of the mandibular bone. Late complications as bone exposure, fracture of the jaw, osteoradionecrosis might be a consequence of this vulnerability. A factor that could be involved in the development of complications is field of radiation. There are limited number of studies investigating this relation. Retrospective analysis of a head and neck oncology register with prospectively included patients will be performed. Patients will be related to the University hospitals in Lund, Umea, Orebro, Stockholm. A thorough analysis of the medical journals in this group of patients will be performed. Included patients have been treated with combination of surgery and radiotherapy to treat malignancies in the head and neck region. At least 12 months follow up period is needed for inclusion. The scientific aim is to investigate weather the field of radiation and fractionation is crucial for developing the formentioned complications.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at how the dose, field size, and delivery schedule of radiation therapy to the head and neck area are related to jaw and bone complications (such as damage to the jaw bone called osteoradionecrosis) in people treated for head and neck cancers. **You may be eligible if...** - You have been diagnosed with a head or neck cancer - You received radiation therapy as part of your treatment (alone or with surgery) - You have been followed up for at least 12 months after treatment - You are 18 or older **You may NOT be eligible if...** - Your follow-up period is less than 12 months - You are under 18 years of age Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONRadiotherapy

Radiotherapy site, time perspective and dose


Locations(1)

Skane University Hospital

Lund, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05412849


Related Trials